ION Exchange (India) / Q3-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2026-02-01Back to IONEXCHANG

Revenue

₹734.44 Cr

verified against source

Revenue YoY

6%

reported change

EBITDA

₹59.3 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
EBITDA (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 68.5 · Watch source sentiment · 2025-11-06Q2 FY26Q3 FY26: 59.3 · Watch source sentiment · 2026-02-01Q3 FY26Q4 FY26: 19.9 · Watch source sentiment · 2026-04-30Q4 FY2668.519.9
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Ion Exchange's Q3 FY26 consolidated revenue grew 6% YoY to INR 734.4 crore, but EBITDA fell 21% to INR 59.3 crore, with margin contracting to 8.07%. The engineering segment was flat due to deferred dispatches of international contracts and muted execution of the UP Jal Jeevan Mission project. The chemical division saw 16% revenue growth but profitability declined 18% due to product mix and Roha facility costs. Consumer products grew 28% but remained loss-making as investments continue. Management expects Q4 to benefit from deferred international invoicing and gradual Roha ramp-up, targeting 25% capacity utilization in FY27. Risks include prolonged UP project fund flow issues and legacy project margin pressure. The budget's increased Jal Jeevan allocation and semiconductor push provide medium-term tailwinds.

Colored figures show movement against the previous available record.

Guidance to track

  • Deferred international project dispatches expected to execute in Q4, boosting revenue and profitability.
  • Management expects to achieve 25% capacity utilization of the Roha resin plant in the next financial year.
  • With continued 30% growth and investment, the division could approach breakeven next year.

Risks flagged

  • Execution of UP projects remains muted due to lack of funding; receivables stuck and order backlog of ~INR 400 crore.
  • A large legacy project continues to impact engineering profitability; execution will extend into FY27.
  • Product approvals from global standards bodies may take longer, delaying revenue ramp-up from the new facility.
  • Company passed on two major semiconductor projects due to unfavorable pricing, indicating competitive pressure.

Key quotes

  • We have become very selective in picking up projects with the right profitability profile.
  • We expect the revenues to significantly increase in the subsequent or the next financial year.
  • We believe that next year we could come close to breaking even in this segment as well.

Research modules

Go one layer deeper.